Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 151 entries
View as:

A Study of MORAb-003 in Patients With Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT01049061 Org: User:
Start: 01/31/10 End: 02/28/13 Due: 02/28/14

Investigation of the Safety and Efficacy of Iguratimod in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01850966 Org: User:
Start: 09/12/12 End: 04/13/14 Due: 04/13/15

An Open-label, Multicenter, Phase 2 Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Previously Treated Subjects With Advanced or Metastatic Soft Tissue Sarcoma (Study E7389-J081-217)

Phase: N/A Priority: Normal
NCT ID: NCT01458249 Org: User:
Start: 11/30/11 End: 02/29/16 Due: 02/28/17

A Study of Equfina® on the Incidences of Adverse Drug Reactions in Participants With Parkinson's Disease (Including Participants With Hepatic Impairment)

Phase: N/A Priority: Normal
NCT ID: NCT04724109 Org: User:
Start: 10/14/20 End: 10/13/22 Due: 10/13/23

Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-

Phase: N/A Priority: Normal
NCT ID: NCT01129596 Org: User:
Start: 06/10/10 End: 06/23/16 Due: 06/23/17

Study to Evaluate the Effect of Diltiazem Extended Release on the Pharmacokinetics of E2027 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02947711 Org: User:
Start: 10/31/16 End: 01/31/17 Due: 01/31/18

A Study of Tazemetostat on Safety in Participants With Relapsed or Refractory Follicular Lymphoma With Enhancer of Zeste Homolog 2 (EZH2) Gene Mutation in Japan

Phase: N/A Priority: Normal
NCT ID: NCT05228158 Org: User:
Start: 08/16/21 End: 03/31/28 Due: 03/31/29

A Dose Response Study of E6011 in Participants With Rheumatoid Arthritis Inadequately Responding to Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT02960438 Org: User:
Start: 10/20/16 End: 09/17/19 Due: 09/17/20

Pharmacokinetics Study of Donepezil HCl in Subjects Receiving Haemodialysis.

Phase: N/A Priority: Normal
NCT ID: NCT01063556 Org: User:
Start: 02/28/10 End: 03/31/10 Due: 03/31/11

A Post-marketing Observational Study of Tasfygo in Participants With Unresectable Biliary Tract Cancer With Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene Positivity Who Progressed After Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT06793709 Org: User:
Start: 08/31/25 End: 11/12/30 Due: 11/12/31

Study of E7389 Liposomal Formulation in Participants With Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT03207672 Org: User:
Start: 08/18/17 End: 03/31/26 Due: 03/31/27

A Study of E7070 in Patients With Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00165594 Org: User:
Start: 02/28/05 End: 08/31/06 Due: 08/31/07

A Double-Blind Study of E5555 in Japanese Subjects With Coronary Artery Disease

Phase: N/A Priority: Normal
NCT ID: NCT00540670 Org: User:
Start: 10/31/07 End: - Due: -

Study to Evaluate the Pharmacokinetics (PK) of E7090 (Herein Referred to as Tasurgratinib) and Its Metabolite in Participants With Mild and Moderate Hepatic Impairment Compared to Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04271488 Org: User:
Start: 02/27/20 End: 11/30/26 Due: 11/30/27

A Study of MORAb-009 in Patients With Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT01018784 Org: User:
Start: 11/30/09 End: 02/28/13 Due: 02/28/14

Study of H3B-6545 in Japanese Women With Estrogen Receptor (ER)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04568902 Org: User:
Start: 09/30/20 End: 03/31/26 Due: 03/31/27

Post-marketing Surveillance of DC Bead in Patients With Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02269995 Org: User:
Start: 03/06/14 End: 12/25/15 Due: 12/25/16

Study of Lenvatinib (E7080) in Participants With Advanced Hepatocellular Carcinoma (HCC)

Phase: N/A Priority: Normal
NCT ID: NCT00946153 Org: User:
Start: 07/24/09 End: 08/13/15 Due: 08/13/16

A Study to Assess the Pharmacodynamics of Lemborexant in Korean Participants With Insomnia Disorder

Phase: N/A Priority: Normal
NCT ID: NCT05594589 Org: User:
Start: 11/30/22 End: 05/24/24 Due: 05/24/25

A Study of Overall Survival in Participants With Unresectable Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04008082 Org: User:
Start: 05/14/19 End: 01/28/22 Due: 01/28/23

Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01251718 Org: User:
Start: 12/01/10 End: 02/18/16 Due: 02/18/17

A Clinical Pharmacological Study of Rabeprazole Sodium in Japanese Healthy Adult Male Volunteers (Study E3810)

Phase: N/A Priority: Normal
NCT ID: NCT01202071 Org: User:
Start: 09/30/10 End: 12/31/10 Due: 12/31/11

A Phase III Study of Eszopiclone in Patients With Insomnia (Study SEP 190-150)

Phase: N/A Priority: Normal
NCT ID: NCT00770692 Org: User:
Start: 10/31/08 End: 05/31/10 Due: 05/31/11

Safety and Efficacy of Mecobalamin Injection in Peripheral Neuropathies Patients (Study JGAZSY091109)

Phase: N/A Priority: Normal
NCT ID: NCT01192113 Org: User:
Start: 04/30/10 End: 05/31/11 Due: 05/31/12

A Clinical Study in Healthy Male Volunteers to Compare the Bioequivalence of Fixed Dose Combination of Eperisone Hydrochloride 50mg Plus Diclofenac Sodium 50mg as Capsule With Eperisone Hydrochloride 50mg and Diclofenac Sodium 50mg Tablets Under Fasting Conditions (Study 013-10)

Phase: N/A Priority: Normal
NCT ID: NCT01306318 Org: User:
Start: 02/28/11 End: 02/28/11 Due: 02/28/12